||
实验性COVID-19疫苗安全,并产生免疫应答
NIAID赞助的1期试验性mRNA疫苗
中期结果显示,一种研究疫苗,即mRNA-1273,其设计目的是抵御SARS-CoV-2,即导致2019年冠状病毒病(COVID-19)的病毒,其耐受性普遍良好,并促进了健康成年人的中和抗体活性。
Experimental COVID-19 vaccine safe, generates immune response
https://www.sciencedaily.com/releases/2020/07/200714171338.htm
Lisa A. Jackson, Evan J. Anderson, Nadine G. Rouphael, Paul C. Roberts, Mamodikoe Makhene, Rhea N. Coler, Michele P. McCullough, James D. Chappell, Mark R. Denison, Laura J. Stevens, Andrea J. Pruijssers, Adrian McDermott, Britta Flach, Nicole A. Doria-Rose, Kizzmekia S. Corbett, Kaitlyn M. Morabito, Sijy O’Dell, Stephen D. Schmidt, Phillip A. Swanson, II, Marcelino Padilla, John R. Mascola, Kathleen M. Neuzil, Hamilton Bennett, Wellington Sun, Etza Peters, Mat Makowski, Jim Albert, Kaitlyn Cross, Wendy Buchanan, Rhonda Pikaart-Tautges, Julie E. Ledgerwood, Barney S. Graham, John H. Beigel, for the mRNA-1273 Study Group. An mRNA Vaccine against SARS-CoV-2 -- Preliminary Report. New England Journal of Medicine, July 14, 2020; DOI: 10.1056/NEJMoa2022483
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-9-27 21:23
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社